# IDEX (IEX)

Sector: Industrial machinery: pumps, valves and fluidics

| Field | Value |
|---|---|
| Price | $219.61 |
| Market cap | $16B |
| Intrinsic value source | Analysts |
| Data as of | 2026-11-20 |
| Next earnings | 2027-02-03 (estimate) |

Analysts: Bullish

Picks: Research only

Discount category: Close to intrinsic value

## In short

The market weighs the strong data center, semiconductor and defense demand of IDEX against weak chemical and energy markets and tariffs, and steady order growth through 2027 can lift its value.

## Themes and gap

- Themes: AI supplier (ai-supplier), Tariffs and trade (trade-tariffs)
- Gap type: Can close (closable)
- Why: The Q4 2026 report, expected in early February 2027, and the 2027 quarters show whether orders from data center and semiconductor customers stay high and industrial markets recover.

## About

IDEX Corporation (IDEX) is based in Northbrook, Illinois. It makes highly engineered products such as fluidic systems and optics, pneumatic components, seals, pumps, valves, water products, dispensing equipment, fire and safety equipment and BAND-IT clamping products. It has three segments: Health & Science Technologies, Fluid & Metering Technologies and Fire & Safety/Diversified Products. Net sales were $951.7 million in Q3 2026 and $2,759.2 million for nine months. The common stock trades on the NYSE in US dollars. IDEX files 10-K and 10-Q reports.

## Thesis

The price of IDEX depends on whether the strong demand from data center power, semiconductor, space and defense markets in its Health & Science Technologies segment continues, and whether its industrial markets recover. In Q3 2026 orders rose 13% to $991.2 million, organic sales rose 8% and adjusted diluted earnings per share rose 15% to $2.33. Organic sales of Health & Science Technologies rose 13%, while Fluid & Metering Technologies had lower volumes in chemical, agriculture and energy markets. IDEX raised its 2026 guidance to adjusted diluted earnings per share of $8.91 to $8.96. For the price to hold or rise, four things must be true. Orders from AI-driven data center and semiconductor customers must stay high. The chemical, agriculture and energy markets must recover. Prices must stay ahead of costs and new tariffs. Acquisitions and share repurchases must earn good returns. The Q4 2026 report, expected in early February 2027, is the next test.

## Checkpoints

- Feb 3, 2027 (estimate): Q4 2026 results and 2027 outlook. Status: Pending. Watch: Adjusted diluted earnings per share for 2026 are in the guided range of $8.91 to $8.96 and orders keep growing, and this passes; a result below the range or falling orders fail.

## Balance sheet

- Cash: $602M
- Debt: $1.8B
- Net debt: $1.2B
- Undrawn credit line: $638M, to September 2031
- Last debt due: 2031

At September 30, 2026, IDEX had total borrowings of $1,759.0 million: $100.0 million of 5.13% senior notes due June 2028, $500.0 million of 4.950% senior notes due September 2029, $500.0 million of 3.00% senior notes due May 2030, $500.0 million of 2.625% senior notes due June 2031 and $158.5 million on its $800.0 million revolving facility, which matures in September 2031. Cash and cash equivalents were $602.1 million. About $637.7 million of the revolving facility was available. Operating cash flow was $543.2 million for nine months. IDEX repurchased 1.1 million shares for $227.0 million in the first nine months of 2026 and pays a quarterly dividend of $0.73 per share.

As of 2026-09-30.

Sources:

- https://www.sec.gov/Archives/edgar/data/832101/000083210126000029/iex-20260930.htm
- https://www.sec.gov/Archives/edgar/data/832101/000083210126000026/iex-20260930xex991.htm

## Dividends

- Dividend yield: 1.3% (last 12 months, at the current price)
- Paid per share, last 12 months: $2.90 (4 payments)
- Current annual rate: $2.92 ($0.73 x 4 a year)
- Payout ratio: 44% of the earnings of the last fiscal year (the year ended 2025-12-31)
- Latest ex-dividend date: 2026-10-02, $0.73 per share
- Growth from 2020 to 2025: 7.1% a year
- Growth from 2016 to 2025: 8.6% a year

Dividends per share by year: 2016: $1.34, 2017: $1.45, 2018: $1.66, 2019: $1.93, 2020: $2.00, 2021: $2.12, 2022: $2.34, 2023: $2.52, 2024: $2.71, 2025: $2.82.

Source: company filings and market data, read on 2026-11-12.

## Recent events

- 2026-10-28: IDEX reported Q3 2026 results. Net sales rose 8% to $951.7 million, diluted earnings per share were $1.95 and adjusted diluted earnings per share were $2.33. Orders rose 13% to $991.2 million. IDEX raised its 2026 guidance for organic sales growth to 6.5% to 6.8% and for adjusted diluted earnings per share to $8.91 to $8.96.
- 2026-09-03: IDEX amended and restated its $800 million revolving credit facility, which now matures in September 2031.
- 2026-08-13: L. Paris Watts-Stanfield resigned from the board of directors, which reduced the board from ten to nine directors.
- 2026-02-20: The US Supreme Court invalidated the tariffs under the International Emergency Economic Powers Act. IDEX collected substantially all of the refunds of these tariffs that it expected in Q2 2026.

## Latest news and filings

- Last earnings: 2026-10-28 (8-K: https://www.sec.gov/Archives/edgar/data/832101/000083210126000026/)
- Next earnings: 2027-02-03 (expected; the company has not confirmed it)

| Filed | Form | Headline | Period end | XBRL document | Link |
| --- | --- | --- | --- | --- | --- |
| 2026-10-28 | 10-Q | Quarterly report for the period ended Sep 30, 2026 | 2026-09-30 | iex-20260930 | https://www.sec.gov/Archives/edgar/data/832101/000083210126000029/iex-20260930.htm |
| 2026-10-28 | 8-K | Earnings release |  | iex-20261028 | https://www.sec.gov/Archives/edgar/data/832101/000083210126000026/ |
| 2026-09-03 | 8-K | New material agreement and New debt or financial obligation |  |  | https://www.sec.gov/Archives/edgar/data/832101/000119312526381880/d421581d8k.htm |
| 2026-08-17 | 8-K | Change of directors or officers |  |  | https://www.sec.gov/Archives/edgar/data/832101/000119312526354040/d371988d8k.htm |
| 2026-07-29 | 10-Q | Quarterly report for the period ended Jun 30, 2026 | 2026-06-30 | iex-20260630 | https://www.sec.gov/Archives/edgar/data/832101/000083210126000022/iex-20260630.htm |
| 2026-07-29 | 8-K | Earnings release |  | iex-20260729 | https://www.sec.gov/Archives/edgar/data/832101/000083210126000019/ |
| 2026-05-08 | 8-K | Shareholder vote results |  | iex-20260506 | https://www.sec.gov/Archives/edgar/data/832101/000083210126000012/iex-20260506.htm |
| 2026-04-29 | 10-Q | Quarterly report for the period ended Mar 31, 2026 | 2026-03-31 | iex-20260331 | https://www.sec.gov/Archives/edgar/data/832101/000083210126000009/iex-20260331.htm |
| 2026-04-29 | 8-K | Earnings release |  | iex-20260429 | https://www.sec.gov/Archives/edgar/data/832101/000083210126000007/ |
| 2026-02-19 | 10-K | Annual report for the period ended Dec 31, 2025 | 2025-12-31 | iex-20251231 | https://www.sec.gov/Archives/edgar/data/832101/000083210126000003/iex-20251231.htm |

Every filing on SEC EDGAR (CIK 832101): https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000832101&type=&dateb=&owner=include&count=40

## Risks

- Medium: Growth depends on AI-driven demand. Higher volumes for data center power and semiconductor markets drove the 13% organic growth of Health & Science Technologies in Q3 2026, and a slowdown in these markets would lower orders.
- Medium: Some industrial markets are weak. Fluid & Metering Technologies had lower volumes in chemical, agriculture and energy markets in Q3 2026.
- Medium: New tariffs can raise costs. After the Supreme Court ruling, the US government put new tariffs in place under other laws, and price and cost pressure partly offset margin gains in Q3 2026.
- Low: Acquisitions add risk. IDEX grows partly by acquisitions, and the amortization of acquired intangible assets was $99.6 million for nine months of 2026.

## Links

- Page: https://picks.utilarium.app/company/IEX/
- History of changes: https://picks.utilarium.app/company/IEX/history/
- JSON with full history: https://picks.utilarium.app/data/company/IEX.json

> Picks is a personal record of stock picks. It gives general opinions about stocks, including a "Top pick" label. They are not tailored to your needs, goals or risk tolerance. Kevin is not a registered adviser and relies on the general-advice exemption in Canadian securities law (NI 31-103 s.8.25). Do your own research, or ask a registered adviser. Kevin may hold any stock on this site. Prices, intrinsic values and ratings can be delayed or wrong; check the original source. Full disclaimer: /disclaimer/.
